Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Collegium Pharmaceutical, Inc. - Common Stock
(NQ:
COLL
)
24.21
-0.95 (-3.78%)
Delayed Quote
Updated: 4:00 PM EST, Nov 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Collegium Pharmaceutical, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Collegium Reports Third Quarter 2026 Financial Results; Reaffirms 2026 Guidance
November 05, 2026
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Pharmaceutical and Boston Legacy FC Expand Their Partnership Beyond Matchday to Communities Across Massachusetts
October 29, 2026
New multi-year partnership combines youth coach training, an annual Sports for All Summit, and sensory inclusion programs to support neurodivergent children and families
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026
October 22, 2026
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Present Pediatric and Real-World Research Across ADHD Portfolio at AACAP and NEI Fall Congresses
October 21, 2026
Seven presentations include pediatric Phase 4 studies of AZSTARYS® (Serdexmethylphenidate/dexmethylphenidate) CII and real-world research of JORNAY PM® (Delayed-Release/Extended-Release...
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Launches "Start Talking ADHD" with Practical Support to Help Families Navigate Care, School and Everyday Life
October 06, 2026
New resource hub builds on Collegium’s growing ADHD portfolio and commitment to supporting people and families beyond the clinical setting
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Participate in Upcoming Investor Conferences
September 08, 2026
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Announces $50 Million Accelerated Share Repurchase Program
August 13, 2026
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress
August 06, 2026
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026
July 23, 2026
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston
July 20, 2026
New headquarters reflects Collegium's long-term vision and commitment to Massachusetts
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 05, 2026
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Participate in 2026 Jefferies Global Healthcare Conference
May 27, 2026
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics
May 12, 2026
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress
May 07, 2026
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Report First Quarter 2026 Financial Results on May 7, 2026
April 23, 2026
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory
March 19, 2026
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Present New Real-World Data at PainConnect 2026
March 05, 2026
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community
March 03, 2026
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Participate in Upcoming Investor Conferences
March 02, 2026
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results
February 26, 2026
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical
February 23, 2026
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Report Fourth Quarter and Full-Year 2025 Financial Results on February 26, 2026
February 12, 2026
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference
January 15, 2026
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Provides 2026 Financial Guidance and Business Update
January 08, 2026
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Announces the Closing of $980 Million Syndicated Credit Facility
December 30, 2025
Five-Year Financing with Favorable Terms that Significantly Reduce Interest Rate
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Participate in Upcoming Investor Conferences
November 12, 2025
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance
November 06, 2025
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment
October 29, 2025
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025
October 23, 2025
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences
October 22, 2025
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
